(Q38944155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

review article

1 reference

title

Region-specific roles of the corticotropin-releasing factor-urocortin system in stress (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Alon Chen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Marloes J A G Henckens

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

English

0 references

publication date

2 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

636-651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27586075%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrn.2016.94

22 March 2020

exact match

0 references

cites work

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Is corticotropin-releasing factor a mediator of stress responses?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF and CRF receptors: role in stress responsivity and other behaviors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of transgenic overproduction of CRH on anxiety-like behaviour

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Peptides that fine-tune the serotonin system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress, memory and the amygdala

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential activation of neuronal cell types in the basolateral amygdala by corticotropin releasing factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Fear extinction learning can be impaired or enhanced by modulation of the CRF system in the basolateral nucleus of the amygdala

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The central amygdala as an integrative hub for anxiety and alcohol use disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Are different parts of the extended amygdala involved in fear versus anxiety?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

β-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Sculpting the hippocampus from within: stress, spines, and CRH

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

A ventral tegmental CRF-glutamate-dopamine interaction in addiction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor: a key role in the neurobiology of addiction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Alcohol in excess: CRF₁ receptors in the rat and mouse VTA and DRN.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Knockdown of CRF1 receptors in the ventral tegmental area attenuates cue- and acute food deprivation stress-induced cocaine seeking in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2+ channels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Nucleus locus ceruleus: new evidence of anatomical and physiological specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Control of arousal through neuropeptide afferents of the locus coeruleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal Fos expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Convergent regulation of locus coeruleus activity as an adaptive response to stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Circuitry underlying regulation of the serotonergic system by swim stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of corticotropin-releasing factor on brain serotonergic activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

5-HT(2A) receptor activation in the dorsolateral septum facilitates inhibitory avoidance in the elevated T-maze

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Overexpression of corticotropin-releasing factor receptor type 2 in the bed nucleus of stria terminalis improves posttraumatic stress disorder-like symptoms in a model of incubation of fear

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Central stress-integrative circuits: forebrain glutamatergic and GABAergic projections to the dorsomedial hypothalamus, medial preoptic area, and bed nucleus of the stria terminalis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Control of stress-induced persistent anxiety by an extra-amygdala septohypothalamic circuit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Synaptic physiology of central CRH system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of synaptic transmission by CRF receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor Circuits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress increases GABAergic neurotransmission in CRF neurons of the central amygdala and bed nucleus stria terminalis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The neuro-symphony of stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The CRF peptide family and their receptors: yet more partners discovered

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Agonist-selective mechanisms of GPCR desensitization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of receptor trafficking by GRKs and arrestins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Clustering with MAGUKs Is Mediated via Its C-Terminal PDZ Binding Motif

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

PDZK1/NHERF3 differentially regulates corticotropin-releasing factor receptor 1 and serotonin 2A receptor signaling and endocytosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

PSD-95 regulates CRFR1 localization, trafficking and β-arrestin2 recruitment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Stress hormone regulation: biological role and translation into therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Sex-specific cell signaling: the corticotropin-releasing factor receptor model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Impairment of synaptic plasticity by the stress mediator CRH involves selective destruction of thin dendritic spines via RhoA signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

NMDA receptor activation and calpain contribute to disruption of dendritic spines by the stress neuropeptide CRH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Memory for emotionally neutral information in posttraumatic stress disorder: A meta-analytic investigation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Effects of stress across the lifespan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Forebrain CRF₁ modulates early-life stress-programmed cognitive deficits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

The behavioural and electrophysiological effects of CRF in rat frontal cortex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2016.94

Corticotropin-releasing factor increases dihydropyridine- and neurotoxin-resistant calcium currents in neurons of the central amygdala.

31 March 2020

1 reference

12 December 2020

Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.

1 reference

12 December 2020

Corticotropin releasing factor receptors and their ligand family

1 reference

12 December 2020

1 reference

12 December 2020

Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior

1 reference

12 December 2020

Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.

1 reference

12 December 2020

1 reference

12 December 2020

Corticotropin-releasing factor enhances brain-derived neurotrophic factor gene expression to facilitate memory retention in rats

1 reference

12 December 2020

Tuning synaptic transmission in the hippocampus by stress: the CRH system

1 reference

12 December 2020

Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area

1 reference

12 December 2020

Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress.

1 reference

12 December 2020

Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro

1 reference

12 December 2020

CRF increases protein phosphorylation and enhances retention performance in rats

1 reference

12 December 2020

Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart

1 reference

12 December 2020